Our work with patient groups aims to improve patients’ health and quality of life, as well as to ensure the quality use of Roche medicines. Additionally, as patient organisations represent the views of patients and their families on issues surrounding healthcare, they help shape the current and future healthcare environment by making their collective voices heard.
Roche collaborates with and provides support to a range of local patient groups in Australia and while doing so applies the principles of the
In 2017, Roche Pharmaceuticals hosted Health Advocacy in Action, a conference attended by 24 senior leaders from 18 major health consumer (patient advocacy) organisations. These leaders represented an aggregate of 9 million patients through their respective organisations – more than a third of Australia’s population.
The conference theme – Achieving a patient-centred healthcare system – reflected an aspiration to elevate the patient voice and ensure patients are the primary focus of the national healthcare system.
Participants at the conference agreed on four recommendations to take forward to health policymakers. These included a focus on evidence-based healthcare investment; broader value recognition; innovation; and data linkage.
To access the conference summary report from Health Advocacy in Action, please click the link below.
Roche Products Pty Limited ABN 70 000 132 865 | Roche Diagnostics Australia Pty Limited ABN 29 003 001 205 | Roche Diabetes Care Australia Pty Limited ABN 69 602 140 278. This website may contain information about products that are not registered for use in your country of residence and may not comply with applicable laws or regulations in that country. We do not take any responsibility for accessing such information in those circumstances. To report a suspected side effect or product complaint associated with the use of a Roche product, visit